| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
455,927 | 443,504 | 418,973 | 444,538 | 651,138 |
|
Cost of Revenue
|
-210,026 | -201,855 | -194,222 | -215,582 | -284,231 |
|
Gross Profit
|
245,901 | 241,649 | 224,751 | 228,956 | 366,907 |
| Selling, General and Administrative Expenses
|
-105,256 | -110,653 | -106,032 | -97,830 | -91,471 |
|
Research and Development Expenses
|
-102,841 | -101,116 | -100,790 | -96,067 | -93,894 |
| Other Income/Expense, Operating
|
6,653 | -19,686 | 0 | 0 | -1,130 |
|
Operating Income/Expenses
|
-201,444 | -231,455 | -206,822 | -193,897 | -186,495 |
|
Total Operating Profit/Loss
|
44,457 | 10,194 | 17,929 | 35,059 | 180,412 |
| Irregular Income/Expenses
|
-6,204 | -- | -- | -- | -- |
|
Other Income/Expense, Non-Operating
|
9,249 | 10,785 | 12,825 | 10,848 | 3,014 |
|
Non-Operating Income/Expenses, Total
|
3,045 | 10,785 | 12,825 | 10,848 | 3,014 |
|
Pretax Income
|
47,502 | 20,979 | 30,754 | 45,907 | 183,426 |
|
Provision for Income Tax
|
-2,762 | 1,114 | 1,480 | 9,828 | -12,575 |
|
Net Income from Continuing Operations
|
44,740 | 22,093 | 32,234 | 55,735 | 170,851 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
44,740 | 22,093 | 32,234 | 55,735 | 170,851 |
|
Net Income after Non-Controlling/Minority Interests
|
44,740 | 22,093 | 32,234 | 55,735 | 170,851 |
|
Net Income Available to Common Stockholders
|
44,740 | 22,093 | 32,234 | 55,735 | 170,851 |
|
Diluted Net Income Available to Common Stockholders
|
44,740 | 22,093 | 32,234 | 55,735 | 170,851 |
| Total Gross Dividends
|
35,848 | -- | -- | -- | -- |
|
Common Dividend per Share
|
0.85 | 0.84 | 0.81 | 0.77 | 0.72 |
| Basic EPS
|
0.80 | 0.39 | 0.57 | 0.97 | 2.96 |
| Diluted EPS
|
0.80 | 0.39 | 0.56 | 0.97 | 2.93 |
|
Basic Weighted Average Shares Outstanding
|
55,607 | 56,063 | 56,820 | 57,195 | 57,801 |
|
Diluted Weighted Average Shares Outstanding
|
56,220.50 | 56,324 | 57,130 | 57,622 | 58,371 |
|
Reported Normalized Diluted EPS
|
1.31 | 1.25 | 1.16 | 1.29 | 3.29 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
47,502 | 20,979 | 30,754 | 45,907 | 183,426 |
|
EBITDA
|
73,429 | 48,979 | 65,354 | 83,307 | 220,726 |
|
Normalized EBITDA
|
106,868 | 88,561 | 100,670 | 111,935 | 244,461 |
|
Normalized Income
|
73,594 | 70,657 | 66,191 | 74,538 | 191,932 |
12/31/2022 - 12/12/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade